Efficacy end points. by Youngmin Ko (3333819)

Subjects:

Pitfalls of merging only considering end-points. by Almiqdad Elzein (13141038)

PowerPoint Slides for: Patiromer Decreases Serum Potassium and Phosphate Levels in Patients on Hemodialysis by Bushinsky D.A. (3246690)

Stable isotope biplots of end-members (colored points) faceted by coastscape and overlayed consumers (gray points). by Nathan D. McTigue (10706460)

Primary and secondary efficacy end points (intention-to-treat population). by Benjamin R. Lewis (22279166)

Knocking down of TRIM59 decreased the expression of cell cycle proteins. by Weihua Zhan (830500)

End-point variability and smallest effective ISS. by James P. Herman (304807)

“…<p>We define baseline end-point variability (σ_b) as: the standard deviation of primary saccade gain during the final 50 trials of the baseline phase. …”

Hamster weight as an end-point for leptospiral infection. by Mariana L. Coutinho (337710)

“…</b> Control animals sham-immunized with phosphate-buffered saline (PBS) had stable or increasing weights until day 8 or 9 after challenge, after which they lost weight and met the end-point criterion of a 10% weight decrease (lines represent individual animals).…”

Binding sites decrease the barrier to folding in hisactophilin. by Shachi Gosavi (160132)

Ifit2 deficiency results in decreased neuroinflammation upon RSA59 infection. by Jayasri Das Sarma (652473)

Prevalence of high-risk HPV types, by HIV status, ranked from left to right by decreasing percentage among total participants. by Taweewat Supindham (733385)

sAB-19 caps the pointed end of actin. by Crista M. Brawley (237517)

“…<p>(A) Visualization of actin nuclei present in TIRF microscopy after 5 minutes of polymerization. We counted only oblong objects as nuclei. In the absence of sAB-19, we observe more actin nuclei, and nuclei decrease as the sAB-19 concentration is increased. …”

Baseline and end-point pain scores in the pregabalin and placebo groups, 2003–2020. by Emma T. L. Cheng (14486376)

Subjects:

Branch points and free ends per unit length. by Lowell T. Edgar (513057)

“…Branching per unit length was observed to decrease as matrix density was increased. An end point was defined as a node that was associated with only one vessel segment and represents the terminal end of a vessel. …”

Table_1_When and Why Did Human Brains Decrease in Size? A New Change-Point Analysis and Insights From Brain Evolution in Ants.XLSX by Jeremy M. DeSilva (7247009)

“…The timing and reason for this decrease is enigmatic. Here we use change-point analysis to estimate the timing of changes in the rate of hominin brain evolution. …”

For each level of risk, we plot the proportion of respondents willing to seek vaccination across ages. by Bert Baumgaertner (3595814)

BC−/EC+ exhibited increased end-systolic and end-diastolic volume and decreased left ventricular function 3 weeks post MI. by Simone Gorressen (605474)

“…<p>BC−/EC+ exhibited an increase in end-systolic (<b>A</b>) and end-diastolic volume (<b>B</b>), a significantly more pronounced decrease in stroke volume (<b>C</b>) (BC+/EC+ n = 8 and BC−/EC+ n = 5; two-way ANOVA and Bonferroni’s post hoc test or student’s t-test; * p<0.05, ** p≤ 0.01 BC+/EC+ vs. …”

Un- and refolding kinetics of CMPK wt – Chevron Plot and end point analysis. by Thorsten Beitlich (478192)

“…While the slow transitions show constant amplitudes (symbols like in (a)), the amplitude of the fast transition decreases and turns negative at 2.0 M urea. (c) End-point analysis of the unfolding and refolding transitions. …”

Descriptive characteristics of children aged 6–59 months in sub-Saharan Africa. by Getayeneh Antehunegn Tesema (9039871)

Data_Sheet_1_Perceptual Priming Can Increase or Decrease With Aging.PDF by Kalathupiriyan A. Zhivago (9659504)

“…However, whether and how implicit perceptual memory varies with aging or cognitive impairment is unclear. Here, we compared implicit perceptual memory and explicit memory measures in three groups of participants: (1) 59 healthy young volunteers (20–30 years); (2) 269 healthy old volunteers (50–90 years) and (3) 21 patients with mild cognitive impairment, i.e., MCI (50–90 years). …”